Figure
The CHRS model uses input variables (blue circle) to calculate the risk of developing any myeloid malignancy and predict overall survival. Inputting the variables from my patient indicated a high-risk assignment. The MN-predict model uses similar input variables as the CHRS model, although several additional clinical and laboratory variables are included (green circle). Unlike the CHRS model, the MN-predict model provides risks for specific categories of myeloid malignancy. For my patient, the model indicated a high-risk of developing MDS or CMML, with lower risks of developing MPN or AML. Abbreviations: variant allele fraction (VAF); mean corpuscular volume (MCV); red cell distribution width (RDW); hemoglobin; PLT, platelet count (HGB); absolute neutrophil count (ANC); reticulocytes (Retic); mean platelet volume (MPV); platelet distribution width (PDW); body mass index (BMI).

The CHRS model uses input variables (blue circle) to calculate the risk of developing any myeloid malignancy and predict overall survival. Inputting the variables from my patient indicated a high-risk assignment. The MN-predict model uses similar input variables as the CHRS model, although several additional clinical and laboratory variables are included (green circle). Unlike the CHRS model, the MN-predict model provides risks for specific categories of myeloid malignancy. For my patient, the model indicated a high-risk of developing MDS or CMML, with lower risks of developing MPN or AML. Abbreviations: variant allele fraction (VAF); mean corpuscular volume (MCV); red cell distribution width (RDW); hemoglobin; PLT, platelet count (HGB); absolute neutrophil count (ANC); reticulocytes (Retic); mean platelet volume (MPV); platelet distribution width (PDW); body mass index (BMI).

Close Modal

or Create an Account

Close Modal
Close Modal